AM Arafat, P Kaczmarek, M Skrzypski… - Diabetologia, 2013 - researchgate.net
Aims/hypothesis Glucagon reduces body weight by modifying food intake, glucose/lipid metabolism and energy expenditure. All these physiological processes are also controlled …
AM Arafat, P Kaczmarek, M Skrzypski… - Diabetologia, 2012 - europepmc.org
Methods The effects of exogenous glucagon on plasma FGF-21 levels and lipolysis were evaluated in healthy volunteers and humans with type 1 diabetes, as well as in rodents with …
AM Arafat, P Kaczmarek, M Skrzypski… - …, 2013 - search.proquest.com
Glucagon reduces body weight by modifying food intake, glucose/lipid metabolism and energy expenditure. All these physiological processes are also controlled by fibroblast …
AM Arafat, P Kaczmarek, M Skrzypski… - Diabetologia, 2013 - academia.edu
Aims/hypothesis Glucagon reduces body weight by modifying food intake, glucose/lipid metabolism and energy expenditure. All these physiological processes are also controlled …
AM Arafat, P Kaczmarek, M Skrzypski… - Diabetologia, 2013 - infona.pl
Aims/hypothesis Glucagon reduces body weight by modifying food intake, glucose/lipid metabolism and energy expenditure. All these physiological processes are also controlled …
AM Arafat, P Kaczmarek, M Skrzypski… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Aims/hypothesis Glucagon reduces body weight by modifying food intake, glucose/lipid metabolism and energy expenditure. All these physiological processes are also controlled …
AM ARAFAT, P KACZMAREK, M SKRZYPSKI… - Diabetologia, 2013 - cat.inist.fr
Aims/hypothesis Glucagon reduces body weight by modifying food intake, glucose/lipid metabolism and energy expenditure. All these physiological processes are also controlled …